Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.
The potent growth-promoting activity of insulin-like growth factor-II (IGF-II) is highly regulated during development but frequently up-regulated in tumors. Increased expression of the normally monoallelic (paternally expressed) mouse (Igf2) and human (IGF2) genes modify progression of intestinal ad...
Príomhchruthaitheoirí: | Harper, J, Burns, J, Foulstone, E, Pignatelli, M, Zaina, S, Hassan, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2006
|
Míreanna comhchosúla
Míreanna comhchosúla
-
The soluble IGF2 receptor reduces small intestine adenoma number in the Apc(Min/+) mouse
de réir: Howell, J, et al.
Foilsithe / Cruthaithe: (2000) -
Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor.
de réir: Prince, SN, et al.
Foilsithe / Cruthaithe: (2007) -
A rapid method for the analysis of cell proliferation and survival in intestinal adenoma from the Apc(Min) mouse
de réir: Burns, J, et al.
Foilsithe / Cruthaithe: (2001) -
Genomic imprinting of <it>IGF2 </it>in marsupials is methylation dependent
de réir: Imumorin Ikhide, et al.
Foilsithe / Cruthaithe: (2008-05-01) -
Maternal transmission of an Igf2r domain 11: IGF2 binding mutant allele (Igf2rI1565A) results in partial lethality, overgrowth and intestinal adenoma progression
de réir: Hughes, J, et al.
Foilsithe / Cruthaithe: (2019)